| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCD2
|
ATP-binding cassette, sub-family D (ALD), member 2
|
|
ABI1
|
abl-interactor 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTB
|
actin, beta
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AFF2
|
AF4/FMR2 family, member 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGRP
|
agouti related neuropeptide
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKR1A1
|
aldo-keto reductase family 1, member A1 (aldehyde reductase)
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALAS1
|
5'-aminolevulinate synthase 1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile)
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL3
|
angiopoietin-like 3
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
AOC3
|
amine oxidase, copper containing 3
|
|
AP4E1
|
adaptor-related protein complex 4, epsilon 1 subunit
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APH1B
|
APH1B gamma secretase subunit
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA2
|
apolipoprotein A-II
|
|
APOB
|
apolipoprotein B
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AR
|
androgen receptor
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGAP18
|
Rho GTPase activating protein 18
|
|
ARHGAP26
|
Rho GTPase activating protein 26
|
|
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1
|
|
ARHGEF17
|
Rho guanine nucleotide exchange factor (GEF) 17
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARSG
|
arylsulfatase G
|
|
ASH2L
|
ash2 (absent, small, or homeotic)-like (Drosophila)
|
|
ATF4
|
activating transcription factor 4
|
|
ATF5
|
activating transcription factor 5
|
|
ATF6
|
activating transcription factor 6
|
|
ATG13
|
autophagy related 13
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATP6AP2
|
ATPase, H+ transporting, lysosomal accessory protein 2
|
|
ATP6V1F
|
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN2
|
ataxin 2
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AXIN1
|
axin 1
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
B2M
|
beta-2-microglobulin
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCCIP
|
BRCA2 and CDKN1A interacting protein
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEST1
|
bestrophin 1
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
BSG
|
basigin (Ok blood group)
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB3
|
BUB3 mitotic checkpoint protein
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C1QTNF5
|
C1q and tumor necrosis factor related protein 5
|
|
C3
|
complement component 3
|
|
CA12
|
carbonic anhydrase XII
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALD1
|
caldesmon 1
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CASP12
|
caspase 12 (gene/pseudogene)
|
|
CASP14
|
caspase 14, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CATSPER1
|
cation channel, sperm associated 1
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CBFA2T2
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 2
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBX3
|
chromobox homolog 3
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCK
|
cholecystokinin
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA1
|
cyclin A1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNE1
|
cyclin E1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCT3
|
chaperonin containing TCP1, subunit 3 (gamma)
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD163
|
CD163 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD2AP
|
CD2-associated protein
|
|
CD300LF
|
CD300 molecule-like family member f
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD69
|
CD69 molecule
|
|
CD83
|
CD83 molecule
|
|
CDC14B
|
cell division cycle 14B
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC37
|
cell division cycle 37
|
|
CDC42
|
cell division cycle 42
|
|
CDC42BPA
|
CDC42 binding protein kinase alpha (DMPK-like)
|
|
CDC6
|
cell division cycle 6
|
|
CDCA8
|
cell division cycle associated 8
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CENPE
|
centromere protein E, 312kDa
|
|
CES1
|
carboxylesterase 1
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHCHD4
|
coiled-coil-helix-coiled-coil-helix domain containing 4
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHMP1B
|
charged multivesicular body protein 1B
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRM4
|
cholinergic receptor, muscarinic 4
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHST6
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIC
|
capicua transcriptional repressor
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLDN5
|
claudin 5
|
|
CLIC1
|
chloride intracellular channel 1
|
|
CLP1
|
cleavage and polyadenylation factor I subunit 1
|
|
CLPTM1L
|
CLPTM1-like
|
|
CNTFR
|
ciliary neurotrophic factor receptor
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPS2
|
COP9 signalosome subunit 2
|
|
CPT1C
|
carnitine palmitoyltransferase 1C
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREG1
|
cellular repressor of E1A-stimulated genes 1
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSRP3
|
cysteine and glycine-rich protein 3 (cardiac LIM protein)
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNAL1
|
catenin (cadherin-associated protein), alpha-like 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTSD
|
cathepsin D
|
|
CTSS
|
cathepsin S
|
|
CUL4A
|
cullin 4A
|
|
CUX1
|
cut-like homeobox 1
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYB5A
|
cytochrome b5 type A (microsomal)
|
|
CYB5B
|
cytochrome b5 type B (outer mitochondrial membrane)
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYTH1
|
cytohesin 1
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCK
|
deoxycytidine kinase
|
|
DCSTAMP
|
dendrocyte expressed seven transmembrane protein
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDX17
|
DEAD (Asp-Glu-Ala-Asp) box helicase 17
|
|
DDX39B
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DDX56
|
DEAD (Asp-Glu-Ala-Asp) box helicase 56
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box helicase 6
|
|
DEK
|
DEK proto-oncogene
|
|
DGKI
|
diacylglycerol kinase, iota
|
|
DHFR
|
dihydrofolate reductase
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
|
DNAJB1P1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 pseudogene 1
|
|
DNM1L
|
dynamin 1-like
|
|
DNM2
|
dynamin 2
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSPP
|
dentin sialophosphoprotein
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
DYSF
|
dysferlin
|
|
E2F1
|
E2F transcription factor 1
|
|
ECD
|
ecdysoneless homolog (Drosophila)
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ECEL1
|
endothelin converting enzyme-like 1
|
|
ECT2
|
epithelial cell transforming 2
|
|
EDEM1
|
ER degradation enhancer, mannosidase alpha-like 1
|
|
EDN1
|
endothelin 1
|
|
EDN3
|
endothelin 3
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EFNB1
|
ephrin-B1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGR1
|
early growth response 1
|
|
EHMT1
|
euchromatic histone-lysine N-methyltransferase 1
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EIF4A2
|
eukaryotic translation initiation factor 4A2
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELN
|
elastin
|
|
ENDOG
|
endonuclease G
|
|
ENG
|
endoglin
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHB2
|
EPH receptor B2
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERLEC1
|
endoplasmic reticulum lectin 1
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ERO1L
|
ERO1-like (S. cerevisiae)
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV1
|
ets variant 1
|
|
ETV4
|
ets variant 4
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXTL3
|
exostosin-like glycosyltransferase 3
|
|
EYA1
|
EYA transcriptional coactivator and phosphatase 1
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBLN1
|
fibulin 1
|
|
FBN1
|
fibrillin 1
|
|
FBXW4
|
F-box and WD repeat domain containing 4
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCAR
|
Fc fragment of IgA receptor
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCMR
|
Fc fragment of IgM receptor
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR1OP2
|
FGFR1 oncogene partner 2
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FHIT
|
fragile histidine triad
|
|
FHL1
|
four and a half LIM domains 1
|
|
FKBP5
|
FK506 binding protein 5
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
|
FLCN
|
folliculin
|
|
FLG
|
filaggrin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMNL1
|
formin-like 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOXC1
|
forkhead box C1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR3
|
formyl peptide receptor 3
|
|
FRA11F
|
fragile site, aphidicolin type, common, fra(11)(q14.2)
|
|
FREM1
|
FRAS1 related extracellular matrix 1
|
|
FRMD5
|
FERM domain containing 5
|
|
FSHMD1A
|
facioscapulohumeral muscular dystrophy 1A
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUS
|
FUS RNA binding protein
|
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase)
|
|
FXN
|
frataxin
|
|
FZD4
|
frizzled class receptor 4
|
|
FZD9
|
frizzled class receptor 9
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2
|
|
GABPB1
|
GA binding protein transcription factor, beta subunit 1
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG3
|
gamma-aminobutyric acid (GABA) A receptor, gamma 3
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA6
|
GATA binding protein 6
|
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
|
|
GBA
|
glucosidase, beta, acid
|
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GDAP1
|
ganglioside induced differentiation associated protein 1
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF5
|
growth differentiation factor 5
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA8
|
gap junction protein, alpha 8, 50kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLIS1
|
GLIS family zinc finger 1
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRH2
|
gonadotropin-releasing hormone 2
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPX2
|
glutathione peroxidase 2
|
|
GRAP
|
GRB2-related adaptor protein
|
|
GRAP2
|
GRB2-related adaptor protein 2
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRHL2
|
grainyhead-like 2 (Drosophila)
|
|
GRIK3
|
glutamate receptor, ionotropic, kainate 3
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRM7
|
glutamate receptor, metabotropic 7
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSX2
|
GS homeobox 2
|
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
|
GUCA1A
|
guanylate cyclase activator 1A (retina)
|
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3
|
|
GUCY2C
|
guanylate cyclase 2C
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
H2AFY
|
H2A histone family, member Y
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBE1
|
hemoglobin, epsilon 1
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HBG1
|
hemoglobin, gamma A
|
|
HCFC1
|
host cell factor C1
|
|
HCRTR2
|
hypocretin (orexin) receptor 2
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC8
|
histone deacetylase 8
|
|
HEXIM1
|
hexamethylene bis-acetamide inducible 1
|
|
HFE
|
hemochromatosis
|
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMGB3
|
high mobility group box 3
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOXA9
|
homeobox A9
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPBP1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1
|
|
HTATSF1
|
HIV-1 Tat specific factor 1
|
|
HTL
|
high L-leucine transport
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
HTR6
|
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA3
|
HtrA serine peptidase 3
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGL
|
immunoglobulin lambda locus
|
|
IHH
|
indian hedgehog
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL11
|
interleukin 11
|
|
IL12A
|
interleukin 12A
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL17RA
|
interleukin 17 receptor A
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RAPL1
|
interleukin 1 receptor accessory protein-like 1
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL27RA
|
interleukin 27 receptor, alpha
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL3
|
interleukin 3
|
|
IL32
|
interleukin 32
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
ILK
|
integrin-linked kinase
|
|
INCENP
|
inner centromere protein antigens 135/155kDa
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSR
|
insulin receptor
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IREB2
|
iron-responsive element binding protein 2
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRGM
|
immunity-related GTPase family, M
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGA7
|
integrin, alpha 7
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB5
|
integrin, beta 5
|
|
ITGB7
|
integrin, beta 7
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JDP2
|
Jun dimerization protein 2
|
|
JPH3
|
junctophilin 3
|
|
JUN
|
jun proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ12
|
potassium channel, inwardly rectifying subfamily J, member 12
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDR
|
kinase insert domain receptor
|
|
KIF6
|
kinesin family member 6
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLC1
|
kinesin light chain 1
|
|
KLC2
|
kinesin light chain 2
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLF9
|
Kruppel-like factor 9
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KNG1
|
kininogen 1
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT14
|
keratin 14, type I
|
|
KRT17
|
keratin 17, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT23
|
keratin 23, type I
|
|
KRT5
|
keratin 5, type II
|
|
KSR1
|
kinase suppressor of ras 1
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LACRT
|
lacritin
|
|
LAMA1
|
laminin, alpha 1
|
|
LAMC2
|
laminin, gamma 2
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
LCE3B
|
late cornified envelope 3B
|
|
LCE3C
|
late cornified envelope 3C
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCMT1
|
leucine carboxyl methyltransferase 1
|
|
LCN2
|
lipocalin 2
|
|
LCT
|
lactase
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LETM1
|
leucine zipper-EF-hand containing transmembrane protein 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIG3
|
ligase III, DNA, ATP-dependent
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIPC
|
lipase, hepatic
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LOX
|
lysyl oxidase
|
|
LPIN2
|
lipin 2
|
|
LPL
|
lipoprotein lipase
|
|
LRIF1
|
ligand dependent nuclear receptor interacting factor 1
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LSAMP
|
limbic system-associated membrane protein
|
|
LTA
|
lymphotoxin alpha
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MACROD1
|
MACRO domain containing 1
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MADD
|
MAP-kinase activating death domain
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
|
|
MALT1
|
MALT1 paracaspase
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP3K13
|
mitogen-activated protein kinase kinase kinase 13
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAP4
|
microtubule-associated protein 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
|
MBD5
|
methyl-CpG binding domain protein 5
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
ME3
|
malic enzyme 3, NADP(+)-dependent, mitochondrial
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED12
|
mediator complex subunit 12
|
|
MED14
|
mediator complex subunit 14
|
|
MED28
|
mediator complex subunit 28
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEP1A
|
meprin A, alpha (PABA peptide hydrolase)
|
|
MEP1B
|
meprin A, beta
|
|
MEPE
|
matrix extracellular phosphoglycoprotein
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFAP4
|
microfibrillar-associated protein 4
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR132
|
microRNA 132
|
|
MIR140
|
microRNA 140
|
|
MIR143
|
microRNA 143
|
|
MIR144
|
microRNA 144
|
|
MIR145
|
microRNA 145
|
|
MIR148B
|
microRNA 148b
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR17
|
microRNA 17
|
|
MIR17HG
|
miR-17-92 cluster host gene
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR187
|
microRNA 187
|
|
MIR18A
|
microRNA 18a
|
|
MIR193A
|
microRNA 193a
|
|
MIR19A
|
microRNA 19a
|
|
MIR19B1
|
microRNA 19b-1
|
|
MIR204
|
microRNA 204
|
|
MIR205
|
microRNA 205
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR214
|
microRNA 214
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR27A
|
microRNA 27a
|
|
MIR30B
|
microRNA 30b
|
|
MIR31
|
microRNA 31
|
|
MIR326
|
microRNA 326
|
|
MIR340
|
microRNA 340
|
|
MIR34C
|
microRNA 34c
|
|
MIR372
|
microRNA 372
|
|
MIR373
|
microRNA 373
|
|
MIR449A
|
microRNA 449a
|
|
MIR92A1
|
microRNA 92a-1
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MIRLET7B
|
microRNA let-7b
|
|
MIRLET7G
|
microRNA let-7g
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MPP5
|
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5)
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH5
|
mutS homolog 5
|
|
MSI2
|
musashi RNA-binding protein 2
|
|
MST1
|
macrophage stimulating 1
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTDH
|
metadherin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH8
|
myosin, heavy chain 8, skeletal muscle, perinatal
|
|
MYO3A
|
myosin IIIA
|
|
MYO7A
|
myosin VIIA
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYT1L
|
myelin transcription factor 1-like
|
|
NANOG
|
Nanog homeobox
|
|
NAPA
|
N-ethylmaleimide-sensitive factor attachment protein, alpha
|
|
NAPSA
|
napsin A aspartic peptidase
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NCK1
|
NCK adaptor protein 1
|
|
NCK2
|
NCK adaptor protein 2
|
|
NCKAP1L
|
NCK-associated protein 1-like
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEK2
|
NIMA-related kinase 2
|
|
NEK3
|
NIMA-related kinase 3
|
|
NES
|
nestin
|
|
NET1
|
neuroepithelial cell transforming 1
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFAM1
|
NFAT activating protein with ITAM motif 1
|
|
NFASC
|
neurofascin
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFIA
|
nuclear factor I/A
|
|
NFIB
|
nuclear factor I/B
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFYA
|
nuclear transcription factor Y, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NHLRC1
|
NHL repeat containing E3 ubiquitin protein ligase 1
|
|
NHP2L1
|
NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae)
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRX1
|
NLR family member X1
|
|
NME2
|
NME/NM23 nucleoside diphosphate kinase 2
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOL4L
|
nucleolar protein 4-like
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPC
|
natriuretic peptide C
|
|
NPR3
|
natriuretic peptide receptor 3
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRGN
|
neurogranin (protein kinase C substrate, RC3)
|
|
NRP1
|
neuropilin 1
|
|
NRXN1
|
neurexin 1
|
|
NTHL1
|
nth endonuclease III-like 1 (E. coli)
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NUP214
|
nucleoporin 214kDa
|
|
NUP98
|
nucleoporin 98kDa
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OLFM3
|
olfactomedin 3
|
|
ONECUT1
|
one cut homeobox 1
|
|
OPTN
|
optineurin
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OSCAR
|
osteoclast associated, immunoglobulin-like receptor
|
|
OSM
|
oncostatin M
|
|
OTC
|
ornithine carbamoyltransferase
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PAK7
|
p21 protein (Cdc42/Rac)-activated kinase 7
|
|
PAM
|
peptidylglycine alpha-amidating monooxygenase
|
|
PAQR7
|
progestin and adipoQ receptor family member VII
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARP2
|
poly (ADP-ribose) polymerase 2
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX2
|
paired box 2
|
|
PAX3
|
paired box 3
|
|
PAX6
|
paired box 6
|
|
PCDH11Y
|
protocadherin 11 Y-linked
|
|
PCDH19
|
protocadherin 19
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
|
PDK2
|
pyruvate dehydrogenase kinase, isozyme 2
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PEAK1
|
pseudopodium-enriched atypical kinase 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PEG3
|
paternally expressed 3
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PER3
|
period circadian clock 3
|
|
PEX7
|
peroxisomal biogenesis factor 7
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHC1
|
polyhomeotic homolog 1 (Drosophila)
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PHKG2
|
phosphorylase kinase, gamma 2 (testis)
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIP5K1C
|
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKP2
|
plakophilin 2
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
|
PLK1
|
polo-like kinase 1
|
|
PLP1
|
proteolipid protein 1
|
|
PLXNA1
|
plexin A1
|
|
PLXNA2
|
plexin A2
|
|
PLXND1
|
plexin D1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PNKP
|
polynucleotide kinase 3'-phosphatase
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLD1
|
polymerase (DNA directed), delta 1, catalytic subunit
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
POLQ
|
polymerase (DNA directed), theta
|
|
PON1
|
paraoxonase 1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU2F3
|
POU class 2 homeobox 3
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPME1
|
protein phosphatase methylesterase 1
|
|
PPP1CC
|
protein phosphatase 1, catalytic subunit, gamma isozyme
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPP6C
|
protein phosphatase 6, catalytic subunit
|
|
PPRC1
|
peroxisome proliferator-activated receptor gamma, coactivator-related 1
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRG4
|
proteoglycan 4
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRKG2
|
protein kinase, cGMP-dependent, type II
|
|
PRL
|
prolactin
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PROS1
|
protein S (alpha)
|
|
PSEN1
|
presenilin 1
|
|
PSMC3
|
proteasome (prosome, macropain) 26S subunit, ATPase, 3
|
|
PSME3
|
proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)
|
|
PSMG1
|
proteasome (prosome, macropain) assembly chaperone 1
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTCH1
|
patched 1
|
|
PTCRA
|
pre T-cell antigen receptor alpha
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
PVT1
|
Pvt1 oncogene (non-protein coding)
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAB11A
|
RAB11A, member RAS oncogene family
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAB6A
|
RAB6A, member RAS oncogene family
|
|
RAB7A
|
RAB7A, member RAS oncogene family
|
|
RABL2A
|
RAB, member of RAS oncogene family-like 2A
|
|
RABL2B
|
RAB, member of RAS oncogene family-like 2B
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RANBP2
|
RAN binding protein 2
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RECQL
|
RecQ helicase-like
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
REPIN1
|
replication initiator 1
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RGS19
|
regulator of G-protein signaling 19
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOG
|
ras homolog family member G
|
|
RINT1
|
RAD50 interactor 1
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RMND5A
|
required for meiotic nuclear division 5 homolog A (S. cerevisiae)
|
|
RNF168
|
ring finger protein 168, E3 ubiquitin protein ligase
|
|
RNF31
|
ring finger protein 31
|
|
RNF41
|
ring finger protein 41, E3 ubiquitin protein ligase
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
ROBO4
|
roundabout, axon guidance receptor, homolog 4 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPL13A
|
ribosomal protein L13a
|
|
RPL3
|
ribosomal protein L3
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RSPO2
|
R-spondin 2
|
|
RSPO3
|
R-spondin 3
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUVBL1
|
RuvB-like AAA ATPase 1
|
|
RUVBL2
|
RuvB-like AAA ATPase 2
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
S1PR4
|
sphingosine-1-phosphate receptor 4
|
|
SAA1
|
serum amyloid A1
|
|
SAR1B
|
secretion associated, Ras related GTPase 1B
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SDC1
|
syndecan 1
|
|
SDC4
|
syndecan 4
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SESN3
|
sestrin 3
|
|
SETBP1
|
SET binding protein 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFN
|
stratifin
|
|
SFTPA1
|
surfactant protein A1
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIM1
|
single-minded family bHLH transcription factor 1
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SIRT4
|
sirtuin 4
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF6
|
SLAM family member 6
|
|
SLAMF7
|
SLAM family member 7
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5
|
|
SLC25A6
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC31A1
|
solute carrier family 31 (copper transporter), member 1
|
|
SLC38A2
|
solute carrier family 38, member 2
|
|
SLC41A1
|
solute carrier family 41 (magnesium transporter), member 1
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC5A8
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMAP1
|
small ArfGAP 1
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCA5
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMCHD1
|
structural maintenance of chromosomes flexible hinge domain containing 1
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNTA1
|
syntrophin, alpha 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SORT1
|
sortilin 1
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SP7
|
Sp7 transcription factor
|
|
SPAST
|
spastin
|
|
SPIN1
|
spindlin 1
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPTA1
|
spectrin, alpha, erythrocytic 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
SRPK1
|
SRSF protein kinase 1
|
|
SRPK2
|
SRSF protein kinase 2
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SSBP3
|
single stranded DNA binding protein 3
|
|
SSFA2
|
sperm specific antigen 2
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAG2
|
stromal antigen 2
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STAU1
|
staufen double-stranded RNA binding protein 1
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK24
|
serine/threonine kinase 24
|
|
STK38L
|
serine/threonine kinase 38 like
|
|
STX16
|
syntaxin 16
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUPT16H
|
suppressor of Ty 16 homolog (S. cerevisiae)
|
|
SUPT4H1
|
suppressor of Ty 4 homolog 1 (S. cerevisiae)
|
|
SUPT5H
|
suppressor of Ty 5 homolog (S. cerevisiae)
|
|
SYK
|
spleen tyrosine kinase
|
|
SYTL5
|
synaptotagmin-like 5
|
|
T
|
T, brachyury homolog (mouse)
|
|
TACC3
|
transforming, acidic coiled-coil containing protein 3
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TAS1R1
|
taste receptor, type 1, member 1
|
|
TAS1R3
|
taste receptor, type 1, member 3
|
|
TBP
|
TATA box binding protein
|
|
TBX4
|
T-box 4
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCEA3
|
transcription elongation factor A (SII), 3
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
TGM3
|
transglutaminase 3
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THPO
|
thrombopoietin
|
|
THRB
|
thyroid hormone receptor, beta
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TJP1
|
tight junction protein 1
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM102
|
transmembrane protein 102
|
|
TMEM173
|
transmembrane protein 173
|
|
TMEM18
|
transmembrane protein 18
|
|
TMEM27
|
transmembrane protein 27
|
|
TMPRSS11D
|
transmembrane protease, serine 11D
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNXB
|
tenascin XB
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPCN2
|
two pore segment channel 2
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRIO
|
trio Rho guanine nucleotide exchange factor
|
|
TRO
|
trophinin
|
|
TROVE2
|
TROVE domain family, member 2
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
TRRAP
|
transformation/transcription domain-associated protein
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSC22D3
|
TSC22 domain family, member 3
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTC1
|
tetratricopeptide repeat domain 1
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
TYK2
|
tyrosine kinase 2
|
|
UBD
|
ubiquitin D
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UCN2
|
urocortin 2
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
USF1
|
upstream transcription factor 1
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VPS45
|
vacuolar protein sorting 45 homolog (S. cerevisiae)
|
|
VTN
|
vitronectin
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
WNT11
|
wingless-type MMTV integration site family, member 11
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
|
WNT2
|
wingless-type MMTV integration site family member 2
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WT2
|
Wilms tumor 2
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPO1
|
exportin 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YAP1
|
Yes-associated protein 1
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
ZBP1
|
Z-DNA binding protein 1
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZNF804A
|
zinc finger protein 804A
|
|
ZW10
|
zw10 kinetochore protein
|
